483
Abbott Laboratories Inc.Abbott Laboratories Inc. – FDA 483, May 2, 2023
Record Details
This FDA Form 483 was issued to Abbott Laboratories Inc. in Casa Grande, AZ, following an inspection of their infant formula manufacturing facility. Observations included failures to establish adequate process controls to prevent microbial adulteration, specifically regarding water event management and environmental pathogen response. Additionally, the firm failed to ensure proper cleaning and sanitization of surfaces that contact infant formula, with inadequate documentation of drying times.
View Company Profile
ID · 4b7b9943-9d5b-4012-a9b4-136d28518047
Other documents for Abbott Laboratories Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.